PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), a company dedicated to oncology orphan products and specialty products today announces the signature of an exclusive license agreement for Sitavig® (Acyclovir Lauriad™) with Abic Marketing Limited ("Teva"), a group subsidiary of Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) for commercialization rights in Israel.
